{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T10:11:22Z","timestamp":1795169482023,"version":"4.10.3"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,6]],"date-time":"2023-04-06T00:00:00Z","timestamp":1680739200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug and Alcohol Dependence"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.drugalcdep.2023.109869","type":"journal-article","created":{"date-parts":[[2023,4,5]],"date-time":"2023-04-05T22:57:23Z","timestamp":1680735443000},"page":"109869","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"special_numbering":"C","title":["Heroin assisted treatment for key health outcomes in people with chronic heroin addictions: A context-focused systematic review"],"prefix":"10.1016","volume":"247","author":[{"given":"Riley","family":"McNair","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Monaghan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Montgomery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drugalcdep.2023.109869_bib1","unstructured":"Adult Substance Misuse Treatment Statistics 2019 to 2020: Report, 2020. Gov.uk \u3008https:\/\/www.gov.uk\/government\/statistics\/substance-misuse-treatment-for-adults-statistics-2019-to-2020\/adult-substance-misuse-treatment-statistics-2019-to-2020-report\u3009."},{"key":"10.1016\/j.drugalcdep.2023.109869_bib2","unstructured":"Adult Substance Misuse Treatment Statistics 2020 to 2021: Report, 2021. Gov.uk. \u3008https:\/\/www.gov.uk\/government\/statistics\/substance-misuse-treatment-for-adults-statistics-2020-to-2021\/adult-substance-misuse-treatment-statistics-2020-to-2021-report\u3009."},{"key":"10.1016\/j.drugalcdep.2023.109869_bib3","unstructured":"Alcohol and Drug Treatment for Adults: Statistics Summary 2017 to 2018, 2018. Gov.uk. \u3008https:\/\/www.gov.uk\/government\/statistics\/substance-misuse-treatment-for-adults-statistics-2017-to-2018\/alcohol-and-drug-treatment-for-adults-statistics-summary-2017-to-2018\u3009."},{"issue":"1","key":"10.1016\/j.drugalcdep.2023.109869_bib4","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1080\/00952990802342899","article-title":"A meta-analysis of retention in methadone maintenance by dose and dosing strategy","volume":"35","author":"Bao","year":"2009","journal-title":"Am. J. Drug Alcohol Abus."},{"issue":"3","key":"10.1016\/j.drugalcdep.2023.109869_bib5","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1080\/10550887.2012.694598","article-title":"Maintenance medication for opiate addiction: the foundation of recovery","volume":"31","author":"Bart","year":"2012","journal-title":"J. Addict. Dis."},{"issue":"13","key":"10.1016\/j.drugalcdep.2023.109869_bib6","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1007\/s40265-018-0962-y","article-title":"Supervised injectable opioid treatment for the management of opioid dependence","volume":"78","author":"Bell","year":"2018","journal-title":"Drugs"},{"key":"10.1016\/j.drugalcdep.2023.109869_bib7","unstructured":"Black, D.C.,2020.Review of Drugs \u2013 Evidence Relating to Drug Use, Supply and Effects, Including Current Trends and Future Risks.\u3008https:\/\/assets.publishing.service.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/882953\/Review_of_Drugs_Evidence_Pack.pdf\u3009."},{"key":"10.1016\/j.drugalcdep.2023.109869_bib8","unstructured":"Black, D.C.,2021. Review of Drugs Part Two: Prevention, Treatment and Recovery: Annexes. \u3008https:\/\/assets.publishing.service.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/1002268\/independent-review-of-drugs-part-2-annexes.pdf\u3009."},{"key":"10.1016\/j.drugalcdep.2023.109869_bib9","series-title":"DeathS Related to Drug Poisoning in England and Wales \u2013 Office for National Statistics","author":"Breen","year":"2022"},{"issue":"5","key":"10.1016\/j.drugalcdep.2023.109869_bib10","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1192\/bjp.bp.112.111583","article-title":"Cost-effectiveness of injectable opioid treatment v. oral methadone for chronic heroin addiction","volume":"203","author":"Byford","year":"2013","journal-title":"Br. J. Psychiatry.: J. Ment. Sci."},{"key":"10.1016\/j.drugalcdep.2023.109869_bib11","unstructured":"Clinical Guidelines on Drug Misuse and Dependence Update 2017 Independent Expert Working Group,2017. Drug Misuse and Dependence: UK Guidelines on Clinical Management. \u3008https:\/\/assets.publishing.service.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/673978\/clinical_guidelines_2017.pdf\u3009."},{"issue":"1","key":"10.1016\/j.drugalcdep.2023.109869_bib12","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/j.1360-0443.2010.03140.x","article-title":"Mortality among regular or dependent users of heroin and other opioids: a systematic review and meta-analysis of cohort studies: Mortality among opioid users","volume":"106","author":"Degenhardt","year":"2011","journal-title":"Addict. (Abingdon, Engl. )"},{"issue":"4","key":"10.1016\/j.drugalcdep.2023.109869_bib13","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1159\/000369337","article-title":"Efficacy of heroin-assisted treatment in Belgium: A randomised controlled trial","volume":"21","author":"Demaret","year":"2015","journal-title":"Eur. Addict. Res."},{"issue":"7410","key":"10.1016\/j.drugalcdep.2023.109869_bib14","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1136\/bmj.327.7410.310","article-title":"Medical prescription of heroin to treatment resistant heroin addicts: two randomised controlled trials","volume":"327","author":"van den Brink","year":"2003","journal-title":"BMJ (Clin. Res. Ed. )"},{"issue":"1","key":"10.1016\/j.drugalcdep.2023.109869_bib15","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1192\/bjp.bp.114.160986","article-title":"Heroin-assisted treatment: has a controversial treatment come of age","volume":"207","author":"Farrell","year":"2015","journal-title":"Br. J. Psychiatry.: J. Ment. Sci."},{"key":"10.1016\/j.drugalcdep.2023.109869_bib16","first-page":"CD003410","article-title":"Heroin maintenance for chronic heroin-dependent individuals","volume":"12","author":"Ferri","year":"2011","journal-title":"Cochrane Database Syst. Rev."},{"issue":"4","key":"10.1016\/j.drugalcdep.2023.109869_bib17","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1007\/s11524-007-9198-y","article-title":"Heroin-assisted treatment (HAT) a decade later: a brief update on science and politics","volume":"84","author":"Fischer","year":"2007","journal-title":"J. Urban Health.: Bull. N. Y. Acad. Med."},{"issue":"3","key":"10.1016\/j.drugalcdep.2023.109869_bib18","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1046\/j.1360-0443.2003.00296.x","article-title":"The National Treatment Outcome Research Study (NTORS): 4-5 year follow-up results: NTORS follow-up results","volume":"98","author":"Gossop","year":"2003","journal-title":"Addict. (Abingdon, Engl. )"},{"issue":"1","key":"10.1016\/j.drugalcdep.2023.109869_bib19","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1192\/bjp.bp.106.026112","article-title":"Heroin-assisted treatment for opioid dependence: Randomised controlled trial","volume":"191","author":"Haasen","year":"2007","journal-title":"Br. J. Psychiatry.: J. Ment. Sci."},{"key":"10.1016\/j.drugalcdep.2023.109869_bib20","unstructured":"Heroin-Assisted Treatment to be Provided in Glasgow, 2022. Scottish Drugs Forum.\u3008https:\/\/www.sdf.org.uk\/heroin-assisted-treatment-provided-glasgow\/\u3009."},{"issue":"2","key":"10.1016\/j.drugalcdep.2023.109869_bib21","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1046\/j.1360-0443.1999.9422216.x","article-title":"The quantification of mortality resulting from the regular use of illicit opiates","volume":"94","author":"Hulse","year":"1999","journal-title":"Addict. (Abingdon, Engl. )"},{"key":"10.1016\/j.drugalcdep.2023.109869_bib22","unstructured":"Injectable Opioid Treatment: Clinical and Operational Elements, 2021. Gov.uk \u3008https:\/\/www.gov.uk\/government\/publications\/injectable-opioid-treatment-commissioning-and-providing-services\/injectable-opioid-treatment-clinical-and-operational-elements\u3009."},{"issue":"6","key":"10.1016\/j.drugalcdep.2023.109869_bib23","doi-asserted-by":"crossref","first-page":"463","DOI":"10.2165\/00023210-200923060-00002","article-title":"Prescription of heroin for the management of heroin dependence: current status: Current status","volume":"23","author":"Lintzeris","year":"2009","journal-title":"CNS Drugs"},{"issue":"1","key":"10.1016\/j.drugalcdep.2023.109869_bib24","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s10979-008-9138-8","article-title":"Explaining the effectiveness of heroin-assisted treatment on crime reductions","volume":"33","author":"L\u00f6bmann","year":"2009","journal-title":"Law Hum. Behav."},{"issue":"2","key":"10.1016\/j.drugalcdep.2023.109869_bib25","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.jsat.2006.04.007","article-title":"Controlled trial of prescribed heroin in the treatment of opioid addiction","volume":"31","author":"March","year":"2006","journal-title":"J. Subst. Abus. Treat."},{"issue":"108984","key":"10.1016\/j.drugalcdep.2023.109869_bib26","article-title":"The suitability of oral diacetylmorphine in treatment-refractory patients with heroin dependence: A scoping review","volume":"227","author":"Martins F","year":"2021","journal-title":"Drug Alcohol Depend."},{"issue":"2","key":"10.1016\/j.drugalcdep.2023.109869_bib27","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1080\/09595230500537175","article-title":"Patients receiving a prescription for diamorphine (heroin) in the United Kingdom","volume":"25","author":"Metrebian","year":"2006","journal-title":"Drug Alcohol Rev."},{"issue":"3","key":"10.1016\/j.drugalcdep.2023.109869_bib28","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1080\/17523281.2010.503937","article-title":"The community impact of RIOTT, a medically supervised injectable maintenance clinic in south London","volume":"3","author":"Miller","year":"2010","journal-title":"Ment. Health Subst. Use.: Dual Diagn."},{"key":"10.1016\/j.drugalcdep.2023.109869_bib29","unstructured":"National Institute on Drug Abuse,2020. Drug Misuse and Addiction. National Institute on Drug Abuse. \u3008https:\/\/nida.nih.gov\/publications\/drugs-brains-behavior-science-addiction\/drug-misuse-addiction\u3009."},{"key":"10.1016\/j.drugalcdep.2023.109869_bib30","unstructured":"NICE,2007. Methadone and Buprenorphine for the Management of Opioid Dependence. \u3008https:\/\/www.nice.org.uk\/guidance\/ta114\/resources\/methadone-and-buprenorphine-for-the-management-of-opioid-dependence-pdf-82598072878789\u3009."},{"key":"10.1016\/j.drugalcdep.2023.109869_bib31","unstructured":"Organisation for Economic Co-operation and Development (OECD),2019. Addressing Problematic Opioid Use in OECD Countries. Organization for Economic Co-operation and Development (OECD)."},{"issue":"8","key":"10.1016\/j.drugalcdep.2023.109869_bib32","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1056\/NEJMoa0810635","article-title":"Diacetylmorphine versus methadone for the treatment of opioid addiction","volume":"361","author":"Oviedo-Joekes","year":"2009","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.drugalcdep.2023.109869_bib33","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1001\/jamapsychiatry.2016.0109","article-title":"Hydromorphone compared with diacetylmorphine for long-term opioid dependence: A randomized clinical trial","volume":"73","author":"Oviedo-Joekes","year":"2016","journal-title":"JAMA Psychiatry (Chic., Ill. )"},{"key":"10.1016\/j.drugalcdep.2023.109869_bib34","first-page":"n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ (Clin. Res. Ed. )"},{"issue":"7150","key":"10.1016\/j.drugalcdep.2023.109869_bib35","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1136\/bmj.317.7150.13","article-title":"Randomised trial of heroin maintenance programme for addicts who fail in conventional drug treatments","volume":"317","author":"Perneger","year":"1998","journal-title":"BMJ (Clin. Res. Ed. )"},{"issue":"1","key":"10.1016\/j.drugalcdep.2023.109869_bib36","doi-asserted-by":"crossref","DOI":"10.1186\/s13012-017-0552-5","article-title":"Making sense of complexity in context and implementation: the Context and Implementation of Complex Interventions (CICI) framework","volume":"12","author":"Pfadenhauer","year":"2017","journal-title":"Implement. Sci.: IS"},{"key":"10.1016\/j.drugalcdep.2023.109869_bib37","unstructured":"Pioneering Heroin Support Programme in Middlesbrough to End after 3 Years Due to Lack of Funding, 2022. Itv.com \u3008https:\/\/www.itv.com\/news\/tyne-tees\/2022-09-29\/pioneering-drug-support-programme-to-end-after-3-years-due-to-lack-of-funding\u3009."},{"key":"10.1016\/j.drugalcdep.2023.109869_bib38","unstructured":"Poulter, H., Crow, R., Moore, H.,2021. Heroin Assisted Treatment (HAT) Pilot Evaluation Report.\u3008https:\/\/research.tees.ac.uk\/ws\/portalfiles\/portal\/25580379\/FINAL_Heroin_Assisted_Treatment_Pilot_Evaluation_Report.pdf\u3009."},{"key":"10.1016\/j.drugalcdep.2023.109869_bib39","unstructured":"PROGRESS-plus,2022. Cochrane.org. \u3008https:\/\/methods.cochrane.org\/equity\/projects\/evidence-equity\/progress-plus\u3009."},{"key":"10.1016\/j.drugalcdep.2023.109869_bib40","unstructured":"Revised Cochrane Risk-of-Bias Tool for Randomized Trials (RoB 2), 2019.\u3008https:\/\/sites.google.com\/site\/riskofbiastool\/welcome\/rob-2-0-tool\/current-version-of-rob-2\u3009."},{"key":"10.1016\/j.drugalcdep.2023.109869_bib41","unstructured":"RevMan,2022. Cochrane.org.\u3008https:\/\/training.cochrane.org\/online-learning\/core-software\/revman\u3009."},{"issue":"3","key":"10.1016\/j.drugalcdep.2023.109869_bib42","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1111\/add.15601","article-title":"Does heroin-assisted treatment reduce crime? A review of randomized-controlled trials","volume":"117","author":"Smart","year":"2022","journal-title":"Addict. (Abingdon, Engl. )"},{"issue":"9729","key":"10.1016\/j.drugalcdep.2023.109869_bib43","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1016\/S0140-6736(10)60349-2","article-title":"Supervised injectable heroin or injectable methadone versus optimised oral methadone as treatment for chronic heroin addicts in England after persistent failure in orthodox treatment (RIOTT): a randomised trial","volume":"375","author":"Strang","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.drugalcdep.2023.109869_bib44","unstructured":"Strang, J., Groshkova, T., Metrebian, N.,2012.EMCDDA INSIGHTS New Heroin-assisted Treatment Recent Evidence and Current Practices of Supervised Injectable Heroin Treatment in Europe and Beyond.\u3008https:\/\/www.emcdda.europa.eu\/system\/files\/publications\/690\/Heroin_Insight_335259.pdf\u3009."},{"issue":"1","key":"10.1016\/j.drugalcdep.2023.109869_bib45","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1192\/bjp.bp.114.149195","article-title":"Heroin on trial: Systematic review and meta-analysis of randomised trials of diamorphine-prescribing as treatment for refractory heroin addiction","volume":"207","author":"Strang","year":"2015","journal-title":"Br. J. Psychiatry.: J. Ment. Sci."},{"key":"10.1016\/j.drugalcdep.2023.109869_bib46","first-page":"19","article-title":"The role and function of heroin assisted treatment at the treatment system level","author":"Uchtenhagen","year":"2017","journal-title":"Heroin Addict. Relat. Clin. Probl."},{"key":"10.1016\/j.drugalcdep.2023.109869_bib47","unstructured":"UNAIDS,2018. Miles To Go: Closing Gaps, Breaking Barriers, Righting Injustices. Unaids.org. \u3008https:\/\/www.unaids.org\/sites\/default\/files\/media_asset\/miles-to-go_en.pdf\u3009."},{"key":"10.1016\/j.drugalcdep.2023.109869_bib48","unstructured":"United Nations Office on Drugs and Crime,2022. World Drug Report 2022: Global Overview Drug Demand Supply. Unodc.org. \u3008https:\/\/www.unodc.org\/res\/wdr2022\/MS\/WDR22_Booklet_2.pdf\u3009."},{"key":"10.1016\/j.drugalcdep.2023.109869_bib49","unstructured":"University of Oslo,2021. HAB - Evaluation of heroin-assisted treatment. Uio.No. \u3008https:\/\/www.med.uio.no\/klinmed\/english\/research\/projects\/hab-evaluation-heroin-assisted-treatment\/\u3009."},{"key":"10.1016\/j.drugalcdep.2023.109869_bib50","unstructured":"White, M., Public Health England,2016.The National Inquiry Into Drug-related Deaths in England.\u3008https:\/\/www.emcdda.europa.eu\/system\/files\/attachments\/3234\/7.%20Plenary%202%20%20Martin%20White%20EMCDDA.pdf\u3009."}],"container-title":["Drug and Alcohol Dependence"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871623001072?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871623001072?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T09:27:05Z","timestamp":1759829225000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0376871623001072"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":50,"alternative-id":["S0376871623001072"],"URL":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2023.109869","relation":{},"ISSN":["0376-8716"],"issn-type":[{"value":"0376-8716","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Heroin assisted treatment for key health outcomes in people with chronic heroin addictions: A context-focused systematic review","name":"articletitle","label":"Article Title"},{"value":"Drug and Alcohol Dependence","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2023.109869","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"109869"}}